In this volume, the contributing authors from top labs involved in stem cell theranostics share the latest advances in the field of stem cell research. The book covers many aspects of stem cell-based therapy and the progress made toward stem cell therapy for liver, ocular, and cardiovascular diseases as well as cancer. This volume serves as a continuation of Prof. Khawaja Husnain Haider's previously edited books pertaining to stem cells-based therapnostics. This is an ideal book for researchers involved in drug development as well as regenerative medicine and stem cell-based therapy. The…mehr
In this volume, the contributing authors from top labs involved in stem cell theranostics share the latest advances in the field of stem cell research. The book covers many aspects of stem cell-based therapy and the progress made toward stem cell therapy for liver, ocular, and cardiovascular diseases as well as cancer. This volume serves as a continuation of Prof. Khawaja Husnain Haider's previously edited books pertaining to stem cells-based therapnostics. This is an ideal book for researchers involved in drug development as well as regenerative medicine and stem cell-based therapy. The secondary audience includes graduate and postgraduate medical students, doctors, cellular pharmacology, drug industry, and researchers involved in using stem cells as ex-vivo disease models for drug development.
Dr. Khawaja Husnain Haider is currently a Professor of Cellular and Molecular Pharmacology (Stem cells and Gene Therapy) and Chairman of the Basic Sciences Department (Medical Program) at Sulaiman AlRajhi University. He has also served on the editorial boards of various research journals and as an invited reviewer for several respected international journals. His research focuses on the use of DNA, miRNAs, and stem cells as "drugs," a topic that has gained popularity in regenerative medicine. He has published over 280 book chapters, abstracts, and papers published in various books and leading research journals including, Circulation, Circulation Research, Cardiovascular Research, JCMM, the Journal of Biological Chemistry, Cell Cycle, Basic Research in Cardiology, and Antioxidant Redox Signaling. He has also given numerous presentations and edited 5 books covering various facets of stem cell and their applications from drug to drug development.
Inhaltsangabe
Micro-Electrode-Arrays: A valuable tool to analyze stem cell derived cardiomyocytes.- CD34+ STEM CELLS AND REGENERATIVE MEDICINE.- Mesenchymal-Hematopoietic Stem Cell Axis: Applications for Induction of Hematopoietic Chimerism and Therapies for Malignancies.- Mesenchymal stem cell-derived secretome: a new remedy for the treatment of autoimmune and inflammatory diseases.- Cardiac regenerative therapy in diabetes: challenges and potential therapeutics.- Macrophage Response to Biomaterials in Cardiovascular Applications.- Evolution of stem cells in cardio-regenerative therapy.- Stem cell-based cardiac regeneration: is there a place for optimism in the future?.- Dental mesenchymal stem/progenitor cells: A new prospect in regenerative medicine.- Stem cell-based tissue engineering for functional enamel and dentin/pulp complex: a potential alternative to the restorative therapies.- Cell and stem cell-based therapies for liver defects: Recent advances and future strategies.- Stem cells: a renewable source of pancreatic beta-cells and future for diabetes treatment.- Induced pluripotent stem cells in pediatric research and clinical translation.- Maturity of Pluripotent Stem Cell-Derived Cardiomyocytes and Future Perspectives for Regenerative Medicine.- Availability of pluripotent stem cells from normal cells in cancer science.- Index.
Micro-Electrode-Arrays: A valuable tool to analyze stem cell derived cardiomyocytes.- CD34+ STEM CELLS AND REGENERATIVE MEDICINE.- Mesenchymal-Hematopoietic Stem Cell Axis: Applications for Induction of Hematopoietic Chimerism and Therapies for Malignancies.- Mesenchymal stem cell-derived secretome: a new remedy for the treatment of autoimmune and inflammatory diseases.- Cardiac regenerative therapy in diabetes: challenges and potential therapeutics.- Macrophage Response to Biomaterials in Cardiovascular Applications.- Evolution of stem cells in cardio-regenerative therapy.- Stem cell-based cardiac regeneration: is there a place for optimism in the future?.- Dental mesenchymal stem/progenitor cells: A new prospect in regenerative medicine.- Stem cell-based tissue engineering for functional enamel and dentin/pulp complex: a potential alternative to the restorative therapies.- Cell and stem cell-based therapies for liver defects: Recent advances and future strategies.- Stem cells: a renewable source of pancreatic beta-cells and future for diabetes treatment.- Induced pluripotent stem cells in pediatric research and clinical translation.- Maturity of Pluripotent Stem Cell-Derived Cardiomyocytes and Future Perspectives for Regenerative Medicine.- Availability of pluripotent stem cells from normal cells in cancer science.- Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826